An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
出版年份 2013 全文链接
标题
An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2013, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2013-01-11
DOI
10.1155/2013/591056
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Update on incretin hormones
- (2012) Liza K. Phillips et al. Annals of the New York Academy of Sciences
- Advanced Glycation End Products and Diabetic Cardiovascular Disease
- (2012) Anand Prasad et al. Cardiology in Review
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- The emerging challenge in diabetes: The “metabolic memory”
- (2012) Antonio Ceriello VASCULAR PHARMACOLOGY
- Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
- (2011) Ravichandran Ramasamy et al. Annals of the New York Academy of Sciences
- AGEs, RAGE, and Diabetic Retinopathy
- (2011) Hongliang Zong et al. Current Diabetes Reports
- Chronic Methylglyoxal Infusion by Minipump Causes Pancreatic β-Cell Dysfunction and Induces Type 2 Diabetes in Sprague-Dawley Rats
- (2011) Arti Dhar et al. DIABETES
- Incretin Effects on -Cell Function, Replication, and Mass: The human perspective
- (2011) A. J. Garber DIABETES CARE
- Sitagliptin Augments Protective Effects of GLP-1 against Advanced Glycation End Product Receptor Axis in Endothelial Cells
- (2011) Y. Ishibashi et al. HORMONE AND METABOLIC RESEARCH
- Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells
- (2011) Miki Minakawa et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Glucagon-like peptide–1 suppresses advanced glycation end product–induced monocyte chemoattractant protein–1 expression in mesangial cells by reducing advanced glycation end product receptor level
- (2011) Yuji Ishibashi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product–receptor axis
- (2011) Takanori Matsui et al. PHARMACOLOGICAL RESEARCH
- AGEs Decrease Insulin Synthesis in Pancreatic β-Cell by Repressing Pdx-1 Protein Expression at the Post-Translational Level
- (2011) Tingting Shu et al. PLoS One
- Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15
- (2010) A. Puddu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Advanced Glycation End-Products affect transcription factors regulating insulin gene expression
- (2010) A. Puddu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells
- (2010) Yunxia Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The RAGE Axis
- (2010) Shi Fang Yan et al. CIRCULATION RESEARCH
- Induction of Apoptosis of β Cells of the Pancreas by Advanced Glycation End-Products, Important Mediators of Chronic Complications of Diabetes Mellitus
- (2009) Minsu Lim et al. Annals of the New York Academy of Sciences
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus
- (2009) Tina Vilsbøll et al. BIODRUGS
- Incretin-Based Therapy of Type 2 Diabetes Mellitus
- (2009) Filip Knop et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of CytochromecOxidase and Adenosine Triphosphate Synthesis
- (2009) Zhengshan Zhao et al. ENDOCRINOLOGY
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
- (2009) Rania Abu-Hamdah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway
- (2009) R. Kimura et al. NEUROSCIENCE
- The Maillard reaction in the human body. The main discoveries and factors that affect glycation
- (2009) F.J. Tessier PATHOLOGIE BIOLOGIE
- Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
- (2009) E.J. Verspohl PHARMACOLOGY & THERAPEUTICS
- The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
- (2008) Robbert Meerwaldt et al. Cardiovascular Diabetology
- Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro
- (2008) Giorgio Luciano Viviani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started